The diastolic pressure in the hypertensive compared with the normotensive subjects showed a distinctly different pattern of response at maximum exercise: in the patients it rose by 11±2 mm Hg while in the normotensive subjects there was no change. A repeat test in eight hypertensive patients three to six months later yielded nearly identical results. 
patients with hypertension baseline systolic blood pressure was 148±2 mm Hg, rising to 207±5 mm Hg at 6000 N m. Baseline diastolic pressure was 100+41 mm Hg, increasing to 111+2 mm Hg at 6000 N m (p<001) and falling to 95±2 mm Hg and 93±3 mm Hg after one and five minutes' rest.
The diastolic pressure in the hypertensive compared with the normotensive subjects showed a distinctly different pattern of response at maximum exercise: in the patients it rose by 11±2 mm Hg while in the normotensive subjects there was no change. A repeat test in eight hypertensive patients three to six months later yielded nearly identical results. 
Comment
It has recently been claimed that changes in blood pressure during exercise may be better correlated with ambulatory measurements than with casual resting blood pressure.' Moreover, assessment of ambulatory pressure may have a predictive value for cardiovascular risks (M Soklow, D Perloff, R Cowan, unpublished observations). Hamer et al2 suggested that during exercise the effect of nervous influences on arterial tone is abolished; therefore, measurements made during exercise may offer a more reliable estimate of the degree of hypertensive vascular changes.
The present study serves as a model for evaluating the bloodpressure response to exercise in normotensive and hypertensive subjects. Hypertensive patients were characterised by a rise in diastolic pressure, while in normotensive subjects diastolic pressure remained unchanged. This rise in diastolic pressure may be attributable to an inability of hypertensive patients to reduce peripheral resistance to the same extent as normotensive subjects during exercise, a phenomenon reported by other workers.3 In contrast to these findings, Lund-Johansen3 reported a rise in diastolic blood pressure in normotensive subjects, but other workers have observed a fall.4 The discrepancy between these studies may be partly due to different methodological approaches, since the position of the body during exercise influences the pattern of response.3
In the present study the mean age was slightly higher in the hypertensive than the normotensive subjects; therefore a comparison was made with an age-matched group of normotensive subjects. Hydralazine-induced lupus erythematosus was observed commonly when the drug was used at high doses, and the daily dose is now customarily limited to 200 mg to avoid this complication. The syndrome still, however, occurs in 3-40% of patients when the dose is limited in this way.' 2 It occurs almost exclusively in slow acetylators. We describe a case of hydralazine-induced lupus erythematosus with transient monoclonal gammopathy, an association that to our knowledge has not been reported before.
Case report
Severe hypertension (250/140 mm Hg) was diagnosed in 1972 in a woman aged 57 years. She had stable mild renal impairment (blood urea concentration 13-15 mmol/l (78-90 mg/100 ml)) and in 1979 suffered a small stroke. In January 1979 hydralazine was started, and she was maintained on 50 mg twice daily from April 1979. In addition she took atenolol, methyldopa, and cyclopenthiazide. In July 1980 (when aged 65 years and after 18 months of treatment with hydralazine, the total dose being about 52 g) she was admitted with a further small stroke, from which she made an uncomplicated recovery.
She complained also of anorexia and general ill health and had lost 15 kg in weight over 18 months (table with hydralazine strongly suggests hydralazine-induced lupus erythematosus; and the patient's complete recovery after the drug was stopped also supported this diagnosis rather than that of idiopathic lupus erythematosus. Increases in plasma immunoglobulin concentrations are common in hydralazine-induced lupus erythematosus,3 but a monoclonal gammopathy has not been reported. Benign monoclonal gammopathies are not uncommon, occurring in about 2% of the population aged over 604; the monoclone generally persists in unchanging concentration over many years. In the present case, however, the IgM kappa monoclone disappeared gradually and completely after hydralazine was stopped, suggesting that the monoclone was part of the lupus syndrome and not a coincidental finding. Transient monoclones may occur rarely-for example, in response to infection or in patients with primary immunodeficiency diseases5-and this case suggests that they may also be caused by drug-induced immunological illness. Hydralazine-induced lupus erythematosus is readily diagnosed when it presents with arthritis, pleurisy, or rash. It may, however, present as an insidious illness characterised by general ill health, considerable weight loss, a high erythrocyte sedimentation rate, and blood dyscrasia. In these circumstances the diagnosis is easily delayed or missed completely and there is a danger that advanced malignancy may be diagnosed incorrectly. The presence of a paraprotein would tend to reinforce this error, and it is important to recognise that monoclonal gammopathy may be a feature of this reversible illness. Hospital, Sheffield S10 2JF S FREESTONE, MB, MRCP, research fellow L E RAMSAY, MB, MRCP, consultant physician and associate in medicine Branhamella catarrhalis infection of the lower respiratory tract: reliable diagnosis by sputum examination Branhamella catarrhalis, an oropharyngeal commensal, has been isolated from the lower respiratory tract by transtracheal puncture in acute exacerbations of chronic chest disease.' Sputum may be contaminated by oropharyngeal commensals while transtracheal puncture enables reliable identification of lower respiratory tract pathogens2 but causes discomfort to the patient. We compared sputum and transtracheal aspirates to investigate the reliability of sputum examination in the diagnosis of lower respiratory tract infection with B catarrhalis.
Patients, methods, and results
Ten men and one woman (mean age 61-5 years, range 35-78) were studied. Ten had chronic chest disease, including chronic bronchitis (3) with emphysema (1) or with asthma (3), bronchiectasis (2), and asthma (1). One, without chronic chest disease, was a heavy cigarette smoker; five were smokers, five ex-smokers, and one a non-smoker. Six were receiving oral corticosteroids for chronic chest disease and, of these six, one also had multiple myeloma and one diabetes mellitus.
B catarrhalis was presumptively identified in sputum by the presence of Gram-negative diplococci in leucocytes and by colonial morphology after growth in direct and quantitative culture on 5%' sheep blood agar and chocolate agar. Transtracheal punctures were then performed and transtracheal aspirates Gram stained and cultured aerobically and anaerobically on 500 sheep blood agar and aerobically on chocolate agar. B catarrhalis was positively identified in sputum and transtracheal aspirates by the criteria of Doern and Morse3 and confirmed by the National Health Institute, Wellington.
B catarrhalis was isolated from 10 of 11 transtracheal aspirates from 11 patients in whom B catarrhalis was identified in sputum. It was isolated in pure culture in four specimens and with other bacteria in six ( 
